Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1CNS 1

Conditions

Thrombocytopenia 1Oligodendroglioma 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 4Surgical Procedures, Operative 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Gadolinium DTPA 2Filgrastim 2Erlotinib Hydrochloride 2Congresses as Topic 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vitespin 1sargramostim 1picropodophyllin 1marizomib 1imetelstat 1gadobutrol 1gadobenic acid 1fluorodopa F 18 1bempegaldesleukin 1antineoplaston AS 2-1 1antineoplaston A10 1Yoga 1Transurethral Resection of Bladder 1Topotecan 1Thiotepa 1Ritonavir 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Perfusion Magnetic Resonance Imaging 1O(6)-benzylguanine 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Ependymoma × Comparative Genomic Hybridization × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡